Breaking News
Title Fluctuations in Panbela Therapeutics Inc Stock Price Factors and Impact
On January 30, 2024, Panbela Therapeutics Inc. (NASDAQ: PBLA) witnessed a significant decline in its stock price, experiencing a staggering...
Surge in Options Activity for CrowdStrike Holdings NASDAQ CRWD Indicates Potential Privileged Information
Investors have been captivated by the recent surge in options activity for CrowdStrike Holdings (NASDAQ: CRWD), indicating potential privileged information....
Acuity Brands Announces Quarterly Dividend and Important Dates
Acuity Brands, a publicly traded company listed on the NYSE under the ticker symbol AYI, has recently made an exciting...
Title Important Reminder Last Chance to Acquire Hanmi Financial Stock Before ExDividend Date
Attention investors! January 30, 2024, marks a crucial date for those interested in purchasing Hanmi Financial (NASDAQ:HAFC) stock. This is...
LSI Industries Announces Quarterly Dividend and Potential for Future Growth
LSI Industries, a publicly traded company on NASDAQ under the ticker symbol LYTS, has recently announced its quarterly dividend of...
Webster Financial Corporation Announces Quarterly Dividend and Key Stock Statistics
Webster Financial Corporation (NYSE: WBS) has recently made an exciting announcement regarding their quarterly dividend. On January 30, 2024, the...
Mizuho Analyst Raises Price Target for ResMed Expresses Bullish Sentiment
On January 30, 2024, Mizuho analyst Anthony Petrone expressed his bullish sentiment towards ResMed (NYSE: RMD) by maintaining a Buy...
Oshkosh Corporation Raises Quarterly Cash Dividend by 122
Oshkosh Corporation, a leading global manufacturer of specialty vehicles and vehicle bodies, has recently made a significant announcement regarding its...
Mizuho Analyst Maintains Buy Rating on Arcus Biosciences with Lowered Price Target
On January 30, 2024, Mara Goldstein, an analyst at Mizuho, expressed her positive outlook on Arcus Biosciences (NYSE:RCUS) by maintaining...
Raymond James Analyst Upgrades Ralph Laurens Price Target Expresses Optimism
On January 30, 2024, Raymond James analyst Rick Patel expressed his optimistic stance on Ralph Lauren (NYSE: RL) by maintaining...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
